Vasiliki Leventaki

Peer-Reviewed Articles

1. E, S, Jelloul, FZ, Nahmod, KA, Short, NJ, Leventaki, V, Jia, F, Xu, J, Loghavi, S, Wang, W, Jabbour, LE, Tang, G, Medeiros, LJ, Wang, S. Acute lymphoblastic leukaemia with T- and B-lineage defining markers. Pathology 57(6):739-745, 2025. e-Pub 2025. PMID: 40318961.
2. Xu, J, Kim, DH, Wang, W, Li, S, Lin, P, Tang, G, Konoplev, SN, Qiu, L, Fang, H, Garces, S, Leventaki, V, Shuyu, E, Medeiros, LJ, Wang, S. Flow cytometric immunophenotypic features of acute myeloid leukemia with mast cell differentiation. American journal of clinical pathology 163(2):240-250, 2025. e-Pub 2025. PMID: 39244687.
3. Shaw, TI, Pounds, S, Cao, X, Ma, J, Palacios, G, Mason, J, Perkins, SL, Wu, G, Fan, Y, Wang, J, Zhou, X, Obermayer, AN, Kinney, MC, Kraveka, JM, Gross, T, Sandlund, JT, Zhang, J, Mullighan, CG, Lim, MS, Leventaki, V. Comprehensive genomic analysis reveals molecular heterogeneity in pediatric ALK-positive anaplastic large cell lymphoma. Leukemia 39(1):199-210, 2025. e-Pub 2025. PMID: 39592809.
4. Dimopoulos, YP, Thakral, B, Lin, P, Toruner, GA, Zuo, Z, Medeiros, LJ, Leventaki, V. From the archives of MD Anderson Cancer Center. Annals of Diagnostic Pathology 73, 2024. e-Pub 2024. PMID: 39208652.
5. Opoku, KB, Santiago, T, Kumar, P, Roush, SM, Fedoriw, Y, Tomoka, T, Leventaki, V, Furtado, LV, Bhakta, N, Alexander, TB, Wang, JR. Transcriptome profiling of pediatric extracranial solid tumors and lymphomas enables rapid low-cost diagnostic classification. Scientific reports 14(1), 2024. e-Pub 2024. PMID: 39169157.
6. Kamens, JL, Dang, J, Shaw, TI, Gout, AM, Newman, S, Hagiwara, K, Smith, AM, Obermayer, AN, Aldridge, S, Ma, J, Zhang, Y, Wu, G, Leventaki, V, Santiago, T, Raimondi, SC, Nakitandwe, J, Pappo, A, Li, CL, Zhang, J, Gruber, TA. Malignant Progression of an Ancestral Bone Marrow Clone Harboring a CIC-NUTM2A Fusion in Isolated Myeloid Sarcoma. Molecular Cancer Research 21(4):301-306, 2023. e-Pub 2023. PMID: 36637394.
7. Ratiani, M, Leventaki, V. Neutrophils and monocytes with increased azurophilic granules resembling toxic changes in mucopolysaccharidosis type VI. Blood 141(7):807, 2023. e-Pub 2023. PMID: 36795445.
8. Lyvannak, S, Khauv, P, Keller, F, Leventaki, V, Camitta, BM. Pyrites. Journal of Pediatric Hematology/Oncology 44(6):347-350, 2022. e-Pub 2022. PMID: 35797179.
9. Lyvannak, S, Sreynich, K, Heng, S, Thyl, M, Chandna, A, Chanpheaktra, N, Pises, N, Farrilend, P, Jarzembowski, J, Leventaki, V, Davick, J, Neunert, C, Keller, F, Kean, LS, Camitta, BM, Tarlock, KG, Watkins, B. Case Report. American Journal of Tropical Medicine and Hygiene 107(2):336-338, 2022. e-Pub 2022. PMID: 35895585.
10. Hopp, AM, Tetzlaff, JE, Kopidlansky, K, Leventaki, V, Parsons, LN, Bone, KM, Drendel, HM, Sreynich, K, Lyvannak, S, Heng, S, Chanpheaktra, N, Putchhat, H, Khauv, P, Camitta, BM, Jarzembowski, J. It Takes a Village. American journal of clinical pathology 158(1):81-95, 2022. e-Pub 2022. PMID: 35050350.
11. Chioureas, D, Beck, J, Baltatzis, GE, Vardaki, I, Fonseca, P, Tsesmetzis, N, Vega Vazquez, F, Leventaki, V, Eliopoulos, A, Drakos, E, Rassidakis, GZ, Panaretakis, T. ALK+ Anaplastic Large Cell Lymphoma (ALCL)-Derived Exosomes Carry ALK Signaling Proteins and Interact with Tumor Microenvironment. Cancers 14(12), 2022. e-Pub 2022. PMID: 35740600.
12. Lyvannak, S, Sreynich, K, Heng, S, Farrilend, P, Keller, F, Tarlock, KG, Leventaki, V, Camitta, BM. Pyrites. Journal of Pediatric Hematology/Oncology 44(3):113-114, 2022. e-Pub 2022. PMID: 35319504.
13. Miller, LJ, Leventaki, V, Harker-Murray, P, Drendel, HM, Bone, KM. A complex KMT2A::AFF3 fusion resulting from a three-way chromosomal rearrangement in pediatric B lymphoblastic leukemia. Cancer Genetics 262-263:43-46, 2022. e-Pub 2022. PMID: 34995897.
14. Wang, S, Oh, DY, Leventaki, V, Drakos, E, Zhang, R, Sahin, AA, Resetkova, E, Edgerton, ME, Wu, W, Claret, F. MicroRNA-17 acts as a tumor chemosensitizer by targeting JAB1/CSN5 in triple-negative breast cancer. Cancer Letters 465:12-23, 2019. e-Pub 2019. PMID: 31473252.
15. Graetz, D, Crews, KR, Azzato, EM, Singh, RK, Raimondi, SC, Mason, J, Valentine, MB, Mullighan, CG, Holland, A, Inaba, H, Leventaki, V. Leukemic presentation of ALK-positive anaplastic large cell lymphoma with a novel partner, poly(A) binding protein cytoplasmic 1 (PABPC1), responding to single-agent crizotinib. Haematologica 104(5):e218-e221, 2019. e-Pub 2019. PMID: 30819904.
16. Rampersaud, E, Ziegler, DS, Iacobucci, I, Payne-Turner, D, Churchman, ML, Schrader, KA, Vijai, J, Offit, K, Tucker, K, Sutton, R, Warby, M, Chenevix-Trench, G, Huntsman, DG, Tsoli, M, Scott Mead, R, Qu, C, Leventaki, V, Wu, G, Mullighan, CG. Germline deletion of ETV6 in familial acute lymphoblastic leukemia. Blood Advances 3(7):1039-1046, 2019. e-Pub 2019. PMID: 30940639.
17. Bjornard, KL, Leventaki, V, Nichols, KE, Sandlund, JT, Prockop, SE, Ehrhardt, MJ. Two-year-old female with EBV-positive diffuse large B-cell lymphoma and subsequent CNS involvement with neurolymphomatosis. Pediatric Blood and Cancer 65(12), 2018. e-Pub 2018. PMID: 30151967.
18. Leventaki, V, Flerlage, JE. Sarcoid-like granulomatosis in a patient receiving anti-TNFα for psoriasis. American journal of hematology 93(5):722-723, 2018. e-Pub 2018. PMID: 29274117.
19. Atsaves, V, Tsesmetzis, N, Chioureas, D, Kis, L, Leventaki, V, Drakos, E, Panaretakis, T, Grandér, D, Medeiros, LJ, Young, KH, Rassidakis, GZ. PD-L1 is commonly expressed and transcriptionally regulated by STAT3 and MYC in ALK-negative anaplastic large-cell lymphoma. Leukemia 31(7):1633-1637, 2017. e-Pub 2017. PMID: 28344319.
20. Helton, KJ, Maron, G, Mamcarz, E, Leventaki, V, Patay, Z, Sadighi, ZS. Unusual magnetic resonance imaging presentation of post-BMT cerebral toxoplasmosis masquerading as meningoencephalitis and ventriculitis. Bone marrow transplantation 51(11):1533-1536, 2016. e-Pub 2016. PMID: 27348541.
21. Ferguson-Paul, K, Mangum, S, Porter, A, Leventaki, V, Campbell, P, Wolf, J. Hemophagocytic lymphohistiocytosis and progressive disseminated histoplasmosis. Emerging Infectious Diseases 22(6):1119-1121, 2016. e-Pub 2016. PMID: 27191972.
22. Ok, CY, Leventaki, V, Wang, S, DiNardo, C, Medeiros, LJ, Konoplev, SN. Detection of an abnormal myeloid clone by flow cytometry in familial platelet disorder with propensity to myeloid malignancy. American journal of clinical pathology 145(2):271-276, 2016. e-Pub 2016. PMID: 26800764.
23. Atsaves, V, Zhang, R, Ruder, D, Pan, Y, Leventaki, V, Rassidakis, GZ, Claret, F. Constitutive control of AKT1 gene expression by JUNB/CJUN in ALK+ anaplastic large-cell lymphoma. Leukemia 29(11):2162-2172, 2015. e-Pub 2015. PMID: 25987255.
24. Atsaves, V, Lekakis, L, Drakos, E, Leventaki, V, Ghaderi, M, Baltatzis, GE, Chioureas, D, Jones, D, Feretzaki, M, Liakou, CI, Panayiotidis, P, Gorgoulis, VG, Patsouris, E, Medeiros, LJ, Claret, F, Rassidakis, GZ. The oncogenic JUNB/CD30 axis contributes to cell cycle deregulation in ALK+ anaplastic large cell lymphoma. British Journal of Haematology 167(4):514-523, 2014. e-Pub 2014. PMID: 25145835.
25. Leventaki, V, Drakos, E, Karanikou, M, Psatha, K, Lin, P, Schlette, EJ, Eliopoulos, A, Vassilakopoulos, TP, Papadaki, H, Patsouris, E, Medeiros, LJ, Rassidakis, GZ. C-JUN N-terminal kinase (JNK) is activated and contributes to tumor cell proliferation in classical Hodgkin lymphoma. Human Pathology 45(3):565-572, 2014. e-Pub 2014. PMID: 24457077.
26. Leventaki, V, Manning, J, Luthra, R, Mehta, P, Oki, Y, Romaguera, JE, Medeiros, LJ, Vega Vazquez, F. Indolent peripheral T-cell lymphoma involving the gastrointestinal tract. Human Pathology 45(2):421-426, 2014. e-Pub 2014. PMID: 24439229.
27. Kunkalla, K, Liu, Y, Qu, C, Leventaki, V, Agarwal, N, Singh, RR, Vega Vazquez, F. Functional inhibition of BCL2 is needed to increase the susceptibility to apoptosis to SMO inhibitors in diffuse large B-cell lymphoma of germinal center subtype. Annals of Hematology 92(6):777-787, 2013. e-Pub 2013. PMID: 23370596.
28. Kim, Y, Leventaki, V, Bhaijee, F, Jackson, CC, Medeiros, LJ, Vega Vazquez, F. Extracavitary/solid variant of primary effusion lymphoma. Annals of Diagnostic Pathology 16(6):441-446, 2012. e-Pub 2012. PMID: 22497739.
29. Leventaki, V, Rodic, V, Tripp, SR, Bayerl, MG, Perkins, SL, Barnette, P, Schiffman, JD, Miles, RR. TP53 pathway analysis in paediatric Burkitt lymphoma reveals increased MDM4 expression as the only TP53 pathway abnormality detected in a subset of cases. British Journal of Haematology 158(6):763-771, 2012. e-Pub 2012. PMID: 22845047.
30. Liakou, P, Tepetes, K, Germenis, A, Leventaki, V, Atsaves, V, Patsouris, E, Roidis, N, Hatzitheophilou, K, Rassidakis, GZ. Expression patterns of endothelin-1 and its receptors in colorectal cancer. Journal of surgical oncology 105(7):643-649, 2012. e-Pub 2012. PMID: 22213082.
31. Drakos, E, Leventaki, V, Atsaves, V, Schlette, EJ, Lin, P, Vega Vazquez, F, Miranda, R, Claret, F, Medeiros, LJ, Rassidakis, GZ. Expression of serine 194-phosphorylated Fas-associated death domain protein correlates with proliferation in B-cell non-Hodgkin lymphomas. Human Pathology 42(8):1117-1124, 2011. e-Pub 2011. PMID: 21315423.
32. Furtado, LV, Leventaki, V, Layfield, LJ, Lowichik, A, Muntz, HR, Pysher, TJ. Yolk sac tumor of the thyroid gland. Pediatric and Developmental Pathology 14(6):475-479, 2011. e-Pub 2011. PMID: 21793665.
33. Tian, L, Peng, G, Parant, JM, Leventaki, V, Drakos, E, Zhang, Q, Parker-Thornburg, J, Shackleford, TJ, Dai, H, Lin, S, Lozano, G, Rassidakis, GZ, Claret, F. Essential roles of Jab1 in cell survival, spontaneous DNA damage and DNA repair. Oncogene 29(46):6125-6137, 2010. e-Pub 2010. PMID: 20802511.
34. Chen, W, Drakos, E, Grammatikakis, I, Schlette, EJ, Li, J, Leventaki, V, Staikou-Drakopoulou, E, Patsouris, E, Panayiotidis, P, Medeiros, LJ, Rassidakis, GZ. MTOR signaling is activated by FLT3 kinase and promotes survival of FLT3-mutated acute myeloid leukemia cells. Molecular cancer 9, 2010. e-Pub 2010. PMID: 21067588.
35. Drakos, E, Rassidakis, GZ, Leventaki, V, Cotta, CV, Vega Vazquez, F, Medeiros, LJ. Nodular lymphocyte predominant hodgkin lymphoma with clusters of lp cells, acute inflammation, and fibrosis. American Journal of Surgical Pathology 33(11):1725-1731, 2009. e-Pub 2009. PMID: 19730363.
36. Inamdar, KV, Romaguera, JE, Drakos, E, Knoblock, RJ, Garcia, M, Leventaki, V, Medeiros, LJ, Rassidakis, GZ. Expression of eukaryotic initiation factor 4E predicts clinical outcome in patients with mantle cell lymphoma treated with hyper-CVAD and rituximab, alternating with rituximab, high-dose methotrexate, and cytarabine. Cancer 115(20):4727-4736, 2009. e-Pub 2009. PMID: 19708031.
37. Chen, W, Konoplev, SN, Medeiros, LJ, Koeppen, H, Leventaki, V, Vadhan, S, Jones, D, Kantarjian, HM, Falini, B, Bueso-Ramos, CE. Cuplike nuclei (prominent nuclear invaginations) in acute myeloid leukemia are highly associated with FLT3 internal tandem duplication and NPM1 mutation. Cancer 115(23):5481-5489, 2009. e-Pub 2009. PMID: 19672946.
38. Drakos, E, Atsaves, V, Li, J, Leventaki, V, Andreeff, M, Medeiros, LJ, Rassidakis, GZ. Stabilization and activation of p53 downregulates mTOR signaling through AMPK in mantle cell lymphoma. Leukemia 23(4):784-790, 2009. e-Pub 2009. PMID: 19225536.
39. Cotta, CV, Leventaki, V, Atsaves, V, Vidaki, A, Schlette, EJ, Jones, D, Medeiros, LJ, Rassidakis, GZ. The helix-loop-helix protein Id2 is expressed differentially and induced by myc in T-cell lymphomas. Cancer 112(3):552-561, 2008. e-Pub 2008. PMID: 18085637.
40. Leventaki, V, Drakos, E, Medeiros, LJ, Lim, MS, Elenitoba-Johnson, KS, Claret, F, Rassidakis, GZ. NPM-ALK oncogenic kinase promotes cell-cycle progression through activation of JNK/cJun signaling in anaplastic large-cell lymphoma. Blood 110(5):1621-1630, 2007. e-Pub 2007. PMID: 17416736.
41. Drakos, E, Thomaides, A, Medeiros, LJ, Li, J, Leventaki, V, Konopleva, M, Andreeff, M, Rassidakis, GZ. Inhibition of p53-murine double minute 2 interaction by nutlin-3A stabilizes p53 and induces cell cycle arrest and apoptosis in Hodgkin lymphoma. Clinical Cancer Research 13(11):3380-3387, 2007. e-Pub 2007. PMID: 17545546.
42. Drakos, E, Rassidakis, GZ, Leventaki, V, Guo, W, Medeiros, LJ, Nagarajan, L. Differential expression of the human MIXL1 gene product in non-Hodgkin and Hodgkin lymphomas. Human Pathology 38(3):500-507, 2007. e-Pub 2007. PMID: 17303500.
43. Drakos, E, Leventaki, V, Schlette, EJ, Jones, D, Lin, P, Medeiros, LJ, Rassidakis, GZ. c-Jun expression and activation are restricted to CD30+ lymphoproliferative disorders. American Journal of Surgical Pathology 31(3):447-453, 2007. e-Pub 2007. PMID: 17325487.
44. Peponi, E, Drakos, E, Reyes, G, Leventaki, V, Rassidakis, GZ, Medeiros, LJ. Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma. American Journal of Pathology 169(6):2171-2180, 2006. e-Pub 2006. PMID: 17148679.
45. Vega Vazquez, F, Medeiros, LJ, Leventaki, V, Atwell, C, Cho-Vega, JH, Tian, L, Claret, F, Rassidakis, GZ. Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma. Cancer Research 66(13):6589-6597, 2006. e-Pub 2006. PMID: 16818631.
46. Oyarzo, M, Medeiros, LJ, Atwell, C, Feretzaki, M, Leventaki, V, Drakos, E, Amin, H, Rassidakis, GZ. c-FLIP confers resistance to FAS-mediated apoptosis in anaplastic large-cell lymphoma. Blood 107(6):2544-2547, 2006. e-Pub 2006. PMID: 16304056.
47. Amin, H, McDonnell, TJ, Ma, Y, Lin, Q, Fujio, Y, Kunisada, K, Leventaki, V, Das, P, Rassidakis, GZ, Cutler, C, Medeiros, LJ, Lai, R. Selective inhibition of STAT3 induces apoptosis and G1 cell cycle arrest in ALK-positive anaplastic large cell lymphoma. Oncogene 23(32):5426-5434, 2004. e-Pub 2004. PMID: 15184887.
48. Amin, H, Medeiros, LJ, Ma, Y, Feretzaki, M, Das, P, Leventaki, V, Rassidakis, GZ, O'Connor, SL, McDonnell, TJ, Lai, R. Inhibition of JAK3 induces apoptosis and decreases anaplastic lymphoma kinase activity in anaplastic large cell lymphoma. Oncogene 22(35):5399-5407, 2003. e-Pub 2003. PMID: 12934099.
49. Amin, H, McDonnell, TJ, Medeiros, LJ, Rassidakis, GZ, Leventaki, V, O'Connor, SL, Keating, MJ, Lai, R. Characterization of 4 mantle cell lymphoma cell lines. Archives of Pathology and Laboratory Medicine 127(4):424-431, 2003. e-Pub 2003. PMID: 12683869.
50. Lai, R, Rassidakis, GZ, Medeiros, LJ, Leventaki, V, Keating, MJ, McDonnell, TJ. Expression of STAT3 and its phosphorylated forms in mantle cell lymphoma cell lines and tumours. Journal of Pathology 199(1):84-89, 2003. e-Pub 2003. PMID: 12474230.
51. Khoury, J, Medeiros, LJ, Rassidakis, GZ, Yared, MA, Tsioli, P, Leventaki, V, Schmitt-Gräff, A, Herling, M, Amin, H, Lai, R. Differential Expression and Clinical Significance of Tyrosinephosphorylated STAT3 in ALK+ and ALK− Anaplastic Large Cell Lymphoma. Clinical Cancer Research 9(10):3692-3699, 2003. e-Pub 2003. PMID: 14506160.
52. Sinatkas, V, Stathopoulou, K, Xagoraris, I, Ye, J, Vyrla, D, Atsaves, V, Leventaki, V, Medeiros, LJ, Rassidakis, GZ, Drakos, E. MDMX/MDM4 is highly expressed and contributes to cell growth and survival in anaplastic large cell lymphoma. Leukemia and Lymphoma 62(7):1563-1573. PMID: 33569988.

Review Articles

1. Alaggio, R, Amador, C, Anagnostopoulos, I, Attygalle, AD, Araujo, I, Berti, E, Bhagat, G, Borges, AM, Boyer, DF, Calaminici, M, Chadburn, A, Chan, JK, Cheuk, W, Chng, WJ, Choi, JK, Chuang, SS, Coupland, SE, Czader, M, Dave, SS, De Jong, D, Du, MQ, Elenitoba-Johnson, KS, Ferry, JA, Geyer, JT, Gratzinger, D, Guitart, J, Gujral, S, Harris, MH, Harrison, CJ, Hartmann, S, Hochhaus, A, Jansen, PM, Karube, K, Kempf, W, Khoury, J, Kimura, H, Klapper, W, Kovach, AE, Kumar, SK, Lazar, A, Lazzi, S, Leoncini, L, Leung, N, Leventaki, V, Li, XQ, Lim, MS, Liu, WP, Louissaint, A, Marcogliese, A, Medeiros, LJ, Michal, M, Miranda, R, Mitteldorf, C, Montes-Moreno, S, Morice, W, Nardi, V, Naresh, KN, Natkunam, Y, Ng, SB, Oschlies, I, Ott, G, Parrens, M, Pulitzer, M, Rajkumar, SV, Rawstron, AC, Rech, K, Rosenwald, A, Said, JW, Sarkozy, C, Sayed, S, Saygin, C, Schuh, A, Sewell, WA, Siebert, R, Sohani, AR, Tooze, R, Traverse-Glehen, A, Vega Vazquez, F, Vergier, B, Wechalekar, A, Wood, B, Xerri, L, Xiao, W. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours. Leukemia 36(7):1720-1748, 2022. e-Pub 2022. PMID: 35732829.
2. Leventaki, V, Bhattacharyya, S, Lim, MS. Pathology and genetics of anaplastic large cell lymphoma. Seminars in Diagnostic Pathology 37(1):57-71, 2020. e-Pub 2020. PMID: 31882178.
3. Atsaves, V, Leventaki, V, Rassidakis, GZ, Claret, F. AP-1 transcription factors as regulators of immune responses in cancer. Cancers 11(7), 2019. e-Pub 2019. PMID: 31340499.

Other Articles

1. Alaggio, R, Amador, C, Anagnostopoulos, I, Attygalle, AD, de Oliveira Araujo, IB, Berti, E, Bhagat, G, Borges, AM, Boyer, DF, Calaminici, M, Chadburn, A, Chan, JK, Cheuk, W, Chng, WJ, Choi, JK, Chuang, SS, Coupland, SE, Czader, M, Dave, SS, De Jong, D, DiNapoli, A, Du, MQ, Elenitoba-Johnson, KS, Ferry, JA, Geyer, JT, Gratzinger, D, Guitart, J, Gujral, S, Harris, MH, Harrison, CJ, Hartmann, S, Hochhaus, A, Jansen, PM, Karube, K, Kempf, W, Khoury, J, Kimura, H, Klapper, W, Kovach, AE, Kumar, SK, Lazar, A, Lazzi, S, Leoncini, L, Leung, N, Leventaki, V, Medeiros, LJ, Miranda, R, Vega Vazquez, F, Burger, JA, Jain, N Correction. Leukemia 37(9):1944-1951, 2023. PMID: 37468552.

Book Chapters

1. Leventaki, V, Khoury, J, Voss, SD. Tumors of lymphoid and hematopoietic tissues. In: Pediatric Malignancies: Pathology and Imaging, 103-149, 2015.
2. Leventaki, V, Vega Vazquez, F. Lymphoid malignancies. In: Molecular Genetic Pathology, 887-928, 2013.

Letters to the Editor

1. Palacios, G, Shaw, TI, Li, Y, Singh, RK, Valentine, MB, Sandlund, JT, Lim, MS, Mullighan, CG, Leventaki, V. Novel ALK fusion in anaplastic large cell lymphoma involving EEF1G, a subunit of the eukaryotic elongation factor-1 complex. Leukemia 31: 743-747, 2017.
2. Ohanian, M, Leventaki, V, Verstovsek, S, Estrov, Z, Lin, P, Yin, CC, Kantarjian, HM, Huh, YO, Ravandi-Kashani, F. Acute lymphoblastic leukemia arising in post-polycythemic myelofibrosis. Leukemia and Lymphoma 53: 1839-1841, 2012.
3. Lai, R, Leventaki, V, Rassidakis, GZ, van den Berg, A, Visser, L, Rust, R, Poppema, S. Re. Journal of Pathology 207: 372-373, 2005.